Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Marksans Pharma Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199226-12-2012
26-12-2012
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Mark Saldanha has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201121-12-2012
Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Mark Saldanha has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE21-12-2012
Outcome of Board Meeting
Marksans Pharma Ltd has informed BSE that pursuant to the Special Resolution passed by the shareholders of the Company at the 19th Annual General Meeting held on 29Ih September, 2011 and in-principle approval received from the Stock Exchange, the Board of Directors of the Company had, at its meeting held on October 25, 2011 issued and allotted 1,75,00,000 Warrants (convertible into equal number of equity shares of Re. 1/- each) to Mr. Mark Saldanha...14-12-2012
Board Meeting on Dec 14, 2012
Marksans Pharma Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on December 14, 2012 to consider conversion of warrants and issue and allot in lieu thereof 1,75,00,000 Equity Shares of Re. 1/- each to Mr. Mark Saldanha, Promoter of the Company on preferential allotment basis.10-12-2012
Financial Results & Limited Review for Sep 30, 2012
Marksans Pharma Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended September 30, 2012.12-11-2012
Outcome of AGM
Marksans Pharma Ltd has informed BSE that the 20th Annual General Meeting (AGM) of the Company was held on September 27, 2012. (For more details kindly refer Corporate Announcements on www.bseindia.com).11-10-2012
Appointment of Director
Marksans Pharma Ltd has informed BSE that Mr. Ajay S. Joshi, who was appointed a Director of the Company in the casual vacancy caused by the resignation of Mr. Kumar Nair, has ceased to be a Director as such effective from the date of the Annual General Meeting i.e. September 27, 2012.Further the Company has informed that, at the 20th Annual General Meeting held on September 27, 2012 appointed Mr. Ajay S. Joshi as a Director of the Company...27-09-2012
Fixes Book Closure for AGM
Marksans Pharma Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 22, 2012 to September 27, 2012 (both days inclusive) for the purpose of 20th Annual General Meeting (AGM) of the Company to be held on September 27, 2012.10-09-2012
Audited Financial Results & Auditors Report for March 31, 2012
Marksans Pharma Ltd has informed BSE about the Audited Financial Results & a copy of the Auditors Report for the period ended March 31, 2012.14-08-2012